Treatment of Resistant Hodgkin’s Lymphoma with Bone Marrow Transplantation in Italy
High-dose chemotherapy and autologous or allogeneic bone marrow transplantation are known to be useful in patients with hematological malignancies. The encouraging results of this approach in the treatment of acute leukemias prompted us to investigate its use in patients with Hodgkin’s lymphoma not being cured by primary conventional chemotherapy.
KeywordsToxicity Lymphoma Leukemia Oncol Neutropenia
Unable to display preview. Download preview PDF.
- Carella AM, Congiu A, Santini G et al. (1986) High dose chemotherapy (HDC) and autologous bone marrow transplantation in advanced highly treated Hodgkin’s disease (AHTHD). Bone Marrow Transplant 1: 293–296Google Scholar
- Carella AM, Congiu A, Santini G et al. (1987) High-dose cyclophosphamide, etoposide and BCNU with autologous BMT (ABMT) rescue in advanced resistant Hodgkin’s disease patients. Bone Marrow Transplant 2 [Suppl 1]: 210Google Scholar
- Jagannath S, Dicke KA, Armitage JO, Cabanillas F, Horwitz U, Vellekoop L, Zander AR, Spitzer G (1986) High dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin’s disease. Ann Intern Med 102: 163–168Google Scholar